trial · primary record
Carvedilol
Cardiotoxicity
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 491 |
| Primary completion | 2031-06-01 |
| Primary endpoint | Time to the first identification of cardiac dysfunction |
| Registry ID | NCT03418961 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:57.165Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03418961
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.